Anti-KAZD1/ KAZALD1/ BONO1 functional antibody

Anti-KAZD1/ KAZALD1/ BONO1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to KAZALD1/KAZALD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1044-Ab-1/ GM-Tg-hg-SE1044-Ab-2Anti-Human KAZALD1 monoclonal antibodyHuman
GM-Tg-rg-SE1044-Ab-1/ GM-Tg-rg-SE1044-Ab-2Anti-Rat KAZALD1 monoclonal antibodyRat
GM-Tg-mg-SE1044-Ab-1/ GM-Tg-mg-SE1044-Ab-2Anti-Mouse KAZALD1 monoclonal antibodyMouse
GM-Tg-cynog-SE1044-Ab-1/ GM-Tg-cynog-SE1044-Ab-2Anti-Cynomolgus/ Rhesus macaque KAZALD1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1044-Ab-1/ GM-Tg-felg-SE1044-Ab-2Anti-Feline KAZALD1 monoclonal antibodyFeline
GM-Tg-cang-SE1044-Ab-1/ GM-Tg-cang-SE1044-Ab-2Anti-Canine KAZALD1 monoclonal antibodyCanine
GM-Tg-bovg-SE1044-Ab-1/ GM-Tg-bovg-SE1044-Ab-2Anti-Bovine KAZALD1 monoclonal antibodyBovine
GM-Tg-equg-SE1044-Ab-1/ GM-Tg-equg-SE1044-Ab-2Anti-Equine KAZALD1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1044-Ab-1/ GM-Tg-hg-SE1044-Ab-2; GM-Tg-rg-SE1044-Ab-1/ GM-Tg-rg-SE1044-Ab-2;
GM-Tg-mg-SE1044-Ab-1/ GM-Tg-mg-SE1044-Ab-2; GM-Tg-cynog-SE1044-Ab-1/ GM-Tg-cynog-SE1044-Ab-2;
GM-Tg-felg-SE1044-Ab-1/ GM-Tg-felg-SE1044-Ab-2; GM-Tg-cang-SE1044-Ab-1/ GM-Tg-cang-SE1044-Ab-2;
GM-Tg-bovg-SE1044-Ab-1/ GM-Tg-bovg-SE1044-Ab-2; GM-Tg-equg-SE1044-Ab-1/ GM-Tg-equg-SE1044-Ab-2
Products NameAnti-KAZALD1 monoclonal antibody
Formatmab
Target NameKAZALD1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-KAZALD1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1044-Ag-1Recombinant multi-species KAZD1/ KAZALD1/ BONO1 protein
    CytokineGM-Tg-g-SE1044-Ag-1Kazal-type serine peptidase inhibitor domain 1 (KAZALD1) protein


    Target information

    Target IDGM-SE1044
    Target NameKAZALD1
    Gene ID81621,107250,293997,711518,609313,101095134,617445,100060342
    Gene Symbol and SynonymsBONO1,FKSG28,FKSG40,IGFBP-rP10,KAZALD1
    Uniprot AccessionQ96I82
    Uniprot Entry NameKAZD1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000107821
    Target ClassificationN/A

    The target: KAZALD1, gene name: KAZALD1, also named as BONO1, FKSG28, FKSG40, IGFBP-rP10. This gene encodes a secreted member of the insulin growth factor-binding protein (IGFBP) superfamily. The protein contains an insulin growth factor-binding domain in its N-terminal region, a Kazal-type serine protease inhibitor and follistatin-like domain in its central region, and an immunoglobulin-like domain in its C-terminal region. Studies of the mouse ortholog suggest that this protein may function in bone development and bone regeneration. This gene is hypomethylated and over-expressed in high-grade glioma compared to low-grade glioma, and thus the hypomethylated gene may be associated with cell proliferation and the shorter survival of patients with high-grade glioma. It is also one of numerous genes found to be deleted in a novel 5.54 Mb interstitial deletion, which is associated with multiple congenital anomalies. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.